Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Nycomed US has completed the acquisition of Bradley Pharmaceuticals, a company focused on niche therapeutic markets in the US.
Subscribe to our email newsletter
With this acquisition, Nycomed will expand the line of dermatological products currently offered through its PharmaDerm Division and thereby increase market coverage and drive future growth. Nycomed expects that the acquisition will provide an enhanced platform for in-licensing and co-promotion of dermatology products, which in turn will build revenues, optimize costs, and increase efficiency.
Nycomed has announced that the PharmaDerm headquarters will be located in Florham Park, New Jersey. The Company will be transitioning key employees from Bradley’s Fairfield corporate headquarters building to Florham Park over the next several months. Nycomed anticipates that the organizations will be fully integrated by year-end.